Invitation to join Edison at the 10th Annual World Stem Cells & Regenerative Medicine Congress 2015
Date: 20 May 2015
Venue: Business Design Centre, 52 Upper Street, London, N1 0QH, UK.
Edison invites you to the 10th Annual World Stem Cells & Regenerative Medicine Congress at the Business Design Centre, London on 20-22 May 2015, where Dr Mick Cooper and Christian Glennie will be hosting an Investor Forum workshop: Developing the economic arguments for your cell therapies: a guide to how and why.
The annual congress is where pharma, biotech, academia, investors, regulatory and governmental bodies meet to discuss the next steps in the commercialisation and collaboration of cell therapies and regenerative medicine globally.
The event gives you the opportunity to join discussions on translating the science, optimising the global regulatory landscape and the latest innovations in cell therapy, tissue engineering and organ regeneration as the industry moves closer to commercialisation.
The conference organisers have offered Edison and its network a 20% discount on the three-day registration pass for those who have not already registered. Click here for the discount rate or contact Andrew Mears on +44 (0)207 092 1228 and quote your unique code EDISON15 if you wish to register by phone. Please note the offer is only applicable to new attendees who are registering and is not available to those who have already registered.
For more information on the event please click here.
Access Edison's Events Online
Please join us for the Edison Charity Bike Ride 2017
Edison, the investment research and advisory company, is once again partnering with the UK’s largest event for private investors. Now in its 15th year, the annual Master Investor Show connects investors with the CEOs and founders of exhibiting companies.
Richard Windsor, Edison's technology analyst is hosting a live webinar at 9am (GMT) on Tuesday 14th March. The webinar will be recorded for Edison TV with material relevant for those with an interest in Artificial Intelligence and the wider market implicat